News

Contact

Billy Clegg/Edward Westropp
Financial Dynamics
26 Southampton Buildings
London
WC2A 1PB

Jul 10

27/07/10	Result of AGM
27/07/10	AGM Statement
02/07/10	Posting of Annual Report and Notice of AGM
02/06/10	Preliminary Results
21/04/10	Close Period Trading Update
22/03/10	Sale of Volplex and Isoplex
04/03/10	IS Pharma acquires exclusive European rights for Episil^®
11/01/10	IS Pharma granted exclusive license and supply rights for Aequasyal^® (oxidised glycerol triester) in the UK
23/11/09	Variquel^® (Haemopressin^®) Update
11/11/09	Notice of Interim Results for the six months ended 30 September 2009
10/11/09	Notification of Major Interests in Shares
01/10/09	Pre‐Close Statement
01/09/09	Repurchase of Deferred Ordinary Shares
07/08/09	Director Shareholding
31/07/09	AGM Statement
31/07/09	Result of AGM
31/07/09	Committee membership
28/07/09	Audit and Remuneration Committee Membership Final
28/07/09	Result of AGM
06/07/09	Annual Reports and Accounts and Notice of AGM
30/06/09	Total Voting Rights
22/06/09	Launch of Variquel™ (Haemopressin^®)
18/06/09	FDA accepts final section of NDA filing for Lucassin
03/06/09	Preliminary Results
21/05/09	Change of Nominated Adviser and Broker
13/05/09	Preliminary Results Announcement
07/05/09	Directorate appointment
16/03/09	Haemopressin MRP Announcement
13/01/09	Directorate changes